Published in J Inherit Metab Dis on October 24, 2016
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.88
Protein and amino acid requirements in human nutrition. World Health Organ Tech Rep Ser (2007) 4.84
The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet (1985) 4.60
Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem (2004) 4.31
Concentrations of choline-containing compounds and betaine in common foods. J Nutr (2003) 4.12
Vision, visual acuity, and ocular refraction of young men: findings in a sample of 1,033 subjects. Br Med J (1960) 3.55
Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med (1983) 3.52
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
HOMOCYSTINURIA. STUDIES OF 20 FAMILIES WITH 38 AFFECTED MEMBERS. JAMA (1965) 3.08
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
Sensory neuropathy with low-dose pyridoxine. Neurology (1985) 2.30
Delay in diagnosis of homocystinuria: retrospective study of consecutive patients. BMJ (1996) 2.21
Molecular genetic testing and the future of clinical genomics. Nat Rev Genet (2013) 2.03
Determination of total homocysteine, methylmalonic acid, and 2-methylcitric acid in dried blood spots by tandem mass spectrometry. Clin Chem (2010) 1.94
Treatment of homocystinuria with a low-methionine diet, supplemental cystine, and a methyl donor. Lancet (1968) 1.90
Chemical chaperones regulate molecular chaperones in vitro and in cells under combined salt and heat stresses. J Biol Chem (2001) 1.78
HOMOCYSTINURIA: CLINICAL AND PATHOLOGICAL REVIEW OF TEN CASES. J Pediatr (1965) 1.77
Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol (2001) 1.71
Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. Clin Chem (1996) 1.68
Hypermethioninemias of genetic and non-genetic origin: A review. Am J Med Genet C Semin Med Genet (2011) 1.55
The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis (1997) 1.51
Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis (1998) 1.50
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet (1999) 1.48
Anesthetic implications of the child with homocystinuria. J Clin Anesth (1994) 1.45
Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes (2008) 1.45
Cystathionine beta-synthase (human). Methods Enzymol (1987) 1.42
The use of betaine in the treatment of elevated homocysteine. Mol Genet Metab (2006) 1.24
Dietary treatment of homocystinuria. Arch Dis Child (1966) 1.23
Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis (2013) 1.22
Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. J Inherit Metab Dis (2015) 1.20
Homocystinuria and Marfan's syndrome. A comparison. J Bone Joint Surg Br (1972) 1.19
Glycine betaine-assisted protein folding in a lysA mutant of Escherichia coli. J Biol Chem (2000) 1.19
Early diagnosis and treatment of homocystinuria. Pediatrics (1966) 1.15
Combined vitamin responsiveness in homocystinuria. J Pediatr (1972) 1.12
Homocystinuria: pathogenetic mechanisms. Am J Med Sci (1977) 1.11
Newborn screening for homocystinuria: Irish and world experience. Eur J Pediatr (1998) 1.09
Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C>T (p.R369C) in the cystathionine beta-synthase gene. J Pediatr (2008) 1.08
Newborn population screening for classic homocystinuria by determination of total homocysteine from Guthrie cards. J Pediatr (2009) 1.07
The ocular histopathology of homocystinuria. A light and electron microscopic study. Am J Ophthalmol (1972) 1.06
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin Thromb Hemost (2000) 1.05
A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency. Mol Genet Metab (2010) 1.04
Vitamin B12 deficiency. N Engl J Med (2013) 1.03
Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med (1983) 1.02
Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr (1998) 1.02
Birth prevalence of homocystinuria. J Pediatr (2004) 1.01
The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment. Hum Mutat (2002) 1.01
Prevalence of congenital homocystinuria in Denmark. N Engl J Med (1999) 1.01
The use of betaine for the treatment of homocystinuria. J Pediatr (1981) 1.01
Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet (1987) 0.99
Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology (2003) 0.99
Total homocysteine measurement in clinical practice. Ann Clin Biochem (2000) 0.98
Dicarboxylic amino acids and glycine-betaine regulate chaperone-mediated protein-disaggregation under stress. Mol Microbiol (2003) 0.98
Dietary management of inborn errors of metabolism. Indian J Pediatr (2002) 0.98
Cerebral edema associated with betaine treatment in classical homocystinuria. J Pediatr (2004) 0.98
Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis (2010) 0.98
Vascular disease and homocysteine metabolism. N Engl J Med (1985) 0.97
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet (2002) 0.97
Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A (2010) 0.95
Classical homocystinuria: vascular risk and its prevention. J Inherit Metab Dis (2003) 0.95
Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients. Metabolism (1983) 0.94
Homocystinuria in New South Wales. Arch Dis Child (1978) 0.93
Homocystinuria versus Marfan's syndrome: the therapeutic relevance of the differential diagnosis. Neth J Med (1984) 0.92
Homocystinuria. A report of two cases and review of the literature. J Bone Joint Surg Am (1969) 0.92
Homocystinuria. Reduced folate levels during pyridoxine treatment. Arch Dis Child (1973) 0.91
Blood spot homocysteine: a feasibility and stability study. Clin Chem (2005) 0.90
Skeletal abnormalities in homocystinuria. Postgrad Med J (1977) 0.90
Safety of pyridoxine--a review of human and animal studies. Toxicol Lett (1986) 0.89
Homocysteine-Induced Endothelial Dysfunction. Ann Nutr Metab (2015) 0.88
Cystathionine beta-synthase is essential for female reproductive function. Hum Mol Genet (2006) 0.88
Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol (2003) 0.88
The Manchester regional screening programme: a 10-year exercise in patient and family care. Br Med J (1979) 0.88
Treatment of inherited homocystinurias. Neuropediatrics (2012) 0.87
Isolated thrombosis due to the cystathionine beta-synthase mutation c.833T>C (1278T). J Inherit Metab Dis (2003) 0.87
Predicting health-related quality of life of parents of children with inherited metabolic diseases. Acta Paediatr (2009) 0.87
The intellectual abilities of early-treated individuals with pyridoxine-nonresponsive homocystinuria due to cystathionine beta-synthase deficiency. J Inherit Metab Dis (2001) 0.87
The roentgenographic features of homocystinuria. Radiology (1968) 0.87
Cystathionine beta-synthase deficiency: effects of betaine supplementation after methionine restriction in B6-nonresponsive homocystinuria. Genet Med (2004) 0.86
Homocystinuria due to cystathionine beta-synthase deficiency associated with megaloblastic anaemia. J Intern Med (2001) 0.86
Expression of cystathionine β-synthase and cystathionine γ-lyase in human pregnant myometrium and their roles in the control of uterine contractility. PLoS One (2011) 0.85
Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method. Ann Clin Biochem (2003) 0.85
Vascular presentation of cystathionine beta-synthase deficiency in adulthood. J Inherit Metab Dis (2010) 0.85
Identification and functional analyses of CBS alleles in Spanish and Argentinian homocystinuric patients. Hum Mutat (2011) 0.85
Molecular neonatal screening for homocystinuria in the Qatari population. Hum Mutat (2009) 0.85
Reproductive fitness in maternal homocystinuria due to cystathionine beta-synthase deficiency. J Inherit Metab Dis (2002) 0.84
Dietary practices in pyridoxine non-responsive homocystinuria: a European survey. Mol Genet Metab (2013) 0.84
Bilateral internal carotid artery dissection in cystathionine beta-synthase deficiency. Eur Neurol (2006) 0.84
Clinical aspects of cystathionine beta-synthase deficiency: how wide is the spectrum? The Italian Collaborative Study Group on Homocystinuria. Eur J Pediatr (1998) 0.84
Post- and prenatal diagnostic methods for the homocystinurias. Eur J Pediatr (1998) 0.84
Betaine in the treatment of homocystinuria. N Engl J Med (1984) 0.84
Genetics of ectopia lentis. Semin Ophthalmol (2013) 0.84
Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria. Mol Genet Metab (2011) 0.83
Cystathionine beta-synthase mutants exhibit changes in protein unfolding: conformational analysis of misfolded variants in crude cell extracts. J Inherit Metab Dis (2011) 0.83
Homocystinuria (cystathionine synthase deficiency). Results of treatment in late-diagnosed patients. Eur J Pediatr (1980) 0.82
Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy. JIMD Rep (2011) 0.82
Social outcome in treated individuals with inherited metabolic disorders: UK study. J Inherit Metab Dis (2005) 0.82
Breast feeding in IMD. J Inherit Metab Dis (2006) 0.82
An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol (2002) 0.82
Pregnancy and homocystinuria. J Obstet Gynaecol Br Commonw (1973) 0.82
Protein substitute dosage in PKU: how much do young patients need? Arch Dis Child (2006) 0.82
Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study. Pediatr Res (2015) 0.83
A recurrent mitochondrial p.Trp22Arg NDUFB3 variant causes a distinctive facial appearance, short stature and a mild biochemical and clinical phenotype. J Med Genet (2016) 0.75
Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing. Arch Dis Child (2017) 0.75